Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2472PDF: 789HTML: 1737 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2150PDF: 1710HTML: 380 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2220PDF: 816HTML: 1634Figure 1: 187Table 1: 211 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3028PDF: 910HTML: 1992 -
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1256PDF: 1008HTML: 223 -
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2825PDF: 1014HTML: 5526 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2598PDF: 751HTML: 2307 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1396HTML: 474PDF: 829 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1376PDF: 845HTML: 139 -
-
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3289PDF: 943HTML: 2959 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1561PDF: 1033HTML: 231 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3571PDF: 2500HTML: 1483 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
733PDF: 466HTML: 6272 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1301PDF: 607HTML: 3103 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2511PDF: 943HTML: 304 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1803PDF: 983HTML: 147 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1634PDF: 818HTML: 173 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1287PDF: 885HTML: 320 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4363PDF: 1767HTML: 1111 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3343PDF: 1323HTML: 6199 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
82PDF: 29HTML: 12 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3267PDF: 1714HTML: 1090
1 - 44 of 44 items







